What does Applied Medical Belgium do?

Applied Medical Belgium is a wholesaler in Brussel. Private Limited, started on 17 June 2022, 1 establishment.

What is the address of Applied Medical Belgium?

The registered office of Applied Medical Belgium is located at Drukpersstraat 4, 1000 Brussel.

Is Applied Medical Belgium still active?

Yes. According to the CBE (31 October 2026) Applied Medical Belgium is active, legal situation “Normale toestand”, started on 17 June 2022.

Is Applied Medical Belgium registered on Peppol?

Yes, Applied Medical Belgium is registered on the Peppol network with ID 0208:0787396708.

What is the enterprise number of Applied Medical Belgium?

The enterprise number of Applied Medical Belgium is BE0787396708.

When was Applied Medical Belgium founded?

Applied Medical Belgium was founded on 17 June 2022.

Who are the directors of Applied Medical Belgium?

According to the 2025 annual accounts, the directors of Applied Medical Belgium are: Maarten Sederel, Christiaan Popma, Dirk Eijgenraam, Robert Van Der Meer.

Is Applied Medical Belgium a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 June 2022; 4 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did Applied Medical Belgium make in 2025?

Applied Medical Belgium posted a profit after taxes of € 229,632 in financial year 2025.

What is the revenue of Applied Medical Belgium?

As a small company, Applied Medical Belgium is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,265,310.

How much does an employee at Applied Medical Belgium earn?

The average wage cost per full-time employee at Applied Medical Belgium was € 157,000 in 2025: staff costs of € 1.9 million for 12 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Applied Medical Belgium have?

According to the 2025 annual accounts, Applied Medical Belgium has 12 full-time equivalents (FTE).

Applied Medical Belgium (Private Limited) - Brussel

Dossier Applied Medical Belgium, printed on 31 October 2026 from databakkes.be/en/0787396708/applied-medical-belgium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Figures corrected NBB

Corrected annual account filed for 2025.
Busy address KBO

50 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

Applied Medical Belgium from Brussel, company number BE0787396708, closed financial year 2025 with a result of € 229,632 after tax. For that financial year Applied Medical Belgium recorded a gross margin of € 2.3 million and equity of € 612,439. Compared with financial year 2024, the result moved from € 216,045 to € 229,632. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 5, 2026.

What it is worth Growing

€ 612,439

▲ 60% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 229,632

▲ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 768,758

▲ 138% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 602,439.

People and assets in 2025

Full-time equivalents

▲ 1.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.9 million

▲ 6% vs 2024

€ 157,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 190,310

▼ 6% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 416,120

▲ 36% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 567,430 Gross margin 2022: € 567,430 First fiscal year in the series	€ 1,921,945 Gross margin 2023: € 1,921,945 ▲ 239% vs 2022 (€ 567,430) Favourable step	€ 2,129,846 Gross margin 2024: € 2,129,846 ▲ 11% vs 2023 (€ 1,921,945) Favourable step	€ 2,265,310 Gross margin 2025: € 2,265,310 ▲ 6% vs 2024 (€ 2,129,846) Favourable step	▲ 6%
Profit after taxes	€ 39,353 Profit after taxes 2022: € 39,353 First fiscal year in the series	€ 117,408 Profit after taxes 2023: € 117,408 ▲ 198% vs 2022 (€ 39,353) Favourable step	€ 216,045 Profit after taxes 2024: € 216,045 ▲ 84% vs 2023 (€ 117,408) Favourable step	€ 229,632 Profit after taxes 2025: € 229,632 ▲ 6% vs 2024 (€ 216,045) Favourable step	▲ 6%
Equity	€ 49,353 Equity 2022: € 49,353 First fiscal year in the series	€ 166,761 Equity 2023: € 166,761 ▲ 238% vs 2022 (€ 49,353) Favourable step	€ 382,806 Equity 2024: € 382,806 ▲ 130% vs 2023 (€ 166,761) Favourable step	€ 612,439 Equity 2025: € 612,439 ▲ 60% vs 2024 (€ 382,806) Favourable step	▲ 60%
Total debts	€ 4,623,670 Total debts 2022: € 4,623,670 First fiscal year in the series	€ 2,493,273 Total debts 2023: € 2,493,273 ▼ 46% vs 2022 (€ 4,623,670) Favourable step	€ 2,371,035 Total debts 2024: € 2,371,035 ▼ 5% vs 2023 (€ 2,493,273) Favourable step	€ 2,827,141 Total debts 2025: € 2,827,141 ▲ 19% vs 2024 (€ 2,371,035) Unfavourable step	▲ 19%
Cash	€ 474,224 Cash 2022: € 474,224 First fiscal year in the series	€ 209,415 Cash 2023: € 209,415 ▼ 56% vs 2022 (€ 474,224) Unfavourable step	€ 322,504 Cash 2024: € 322,504 ▲ 54% vs 2023 (€ 209,415) Favourable step	€ 768,758 Cash 2025: € 768,758 ▲ 138% vs 2024 (€ 322,504) Favourable step	▲ 138%
Retained profit	€ 39,353 Retained profit 2022: € 39,353 First fiscal year in the series	€ 156,761 Retained profit 2023: € 156,761 ▲ 298% vs 2022 (€ 39,353) Favourable step	€ 372,806 Retained profit 2024: € 372,806 ▲ 138% vs 2023 (€ 156,761) Favourable step	€ 602,439 Retained profit 2025: € 602,439 ▲ 62% vs 2024 (€ 372,806) Favourable step	▲ 62%
Balance sheet total	€ 4,673,023 Balance sheet total 2022: € 4,673,023 First fiscal year in the series	€ 2,660,034 Balance sheet total 2023: € 2,660,034 ▼ 43% vs 2022 (€ 4,673,023) Unchanged	€ 2,753,841 Balance sheet total 2024: € 2,753,841 ▲ 4% vs 2023 (€ 2,660,034) Unchanged	€ 3,439,579 Balance sheet total 2025: € 3,439,579 ▲ 25% vs 2024 (€ 2,753,841) Unchanged	▲ 25%
Employees (FTE)	2.8 Employees (FTE) 2022: 2.8 First fiscal year in the series	10.7 Employees (FTE) 2023: 10.7 ▲ 7.9 vs 2022 (2.8) Unchanged	10.7 Employees (FTE) 2024: 10.7 Unchanged (10.7) Unchanged	12 Employees (FTE) 2025: 12 ▲ 1.3 vs 2024 (10.7) Unchanged	▲ 1.3

Key figures of Applied Medical Belgium, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Applied Medical Belgium?

What happened at Applied Medical Belgium in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 5, 2026 Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
2025 Robert Van Der Meer stepped down as director. NBB
2024 Christiaan Popma became a director. NBB
2023 Maarten Sederel became a director. NBB
Jun 17, 2022 New establishment in Brussel. KBO
2022 Dirk Eijgenraam became a director. NBB
2022 Robert Van Der Meer became a director. NBB
Jun 17, 2022 Start of the company according to the CBE. KBO

In short

From € 39,353 profit in 2022 to € 229,632 profit in 2025.

Paid € 255,177 in corporate taxes since 2022.

Best year ever: 2025, with € 229,632 profit.

On average € 188,800 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Applied Medical Europe BV 100%

Applied Medical Belgium

Behind Applied Medical Belgium are Maarten Sederel, Christiaan Popma and Dirk Eijgenraam. The shares are held by Applied Medical Europe BV (100%).

Directors

According to the 2025 annual accounts

Maarten Sederel

Director

since 2023

Christiaan Popma

Director

since 2024

Dirk Eijgenraam

Director

since 2022

Robert Van Der Meer

Director

since 2022 · until 2025

Shareholders

Applied Medical Europe BV

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Drukpersstraat 4

1000 Brussel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 50 companies are registered at this address.

All companies at this address →

Grada

Société de Gestion patrimoniale et financière

€ 557,981 gross margin · 2026

Schalbroek

€ -20,347 gross margin · 2025

Immobilière du Boulevard

€ 31,024 gross margin · 2025

Société anonyme belge de la Forêt du Paular

€ -93,395 gross margin · 2025

+45 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0787.396.708

VAT number

BE 0787.396.708

Registered office

Drukpersstraat 4, 1000 Brussel

Names & denominations

Applied Medical Belgium

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

17 June 2022

Peppol

Active · Active since 9 Feb 2023

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Verhuur en lease van medisch en paramedisch materieel

Handelsbemiddeling in de niet-gespecialiseerde groothandel

View on CBE Public ↗ Annual accounts (NBB) ↗

Applied Medical Belgium

Warning lights

Financials

What happened to Applied Medical Belgium?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions